Although this is in contrast with findings from previous studies where overexpression of ALDOA has been associated with cardiac hypertrophy and fibrosis, there was a significant positive correlation between ALDOA and left ventricular end diastolic volume (LVEDV, Figure 3), suggesting a clinically relevant role in the disease. Here, ALDOA is linked to cardiac hypertrophy.